RESEARCH TRIANGLE PARK – GlaxoSmithKline disclosed its latest financials report Wednesday in London, and CEO Emma Walmsley offered her analysis via YouTube.
Shares (NYSE: GSK) are up on the news with one bright shot being its shingles vaccine.
“The shingles vaccine generated 698 million pounds in quarterly sales, beating analyst estimates of 528 million,” Reuters reported.
Here’s the video:
Read the full report online at this site:
https://www.gsk.com/en-gb/investors/quarterly-results/
GSK employs thousands of people across the Triangle, from research and development to manufacturing.
